Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Lymphoma, Large B-Cell, Diffuse 21Lymphoma 20Lymphoma, Follicular 16Leukemia, Lymphocytic, Chronic, B-Cell 15Lymphoma, Non-Hodgkin 10Lymphoma, Mantle-Cell 9Lymphoma, B-Cell, Marginal Zone 9Leukemia 9Recurrence 6Burkitt Lymphoma 6Waldenstrom Macroglobulinemia 5Lymphoma, B-Cell 4Lymphoma, Large-Cell, Immunoblastic 3Hodgkin Disease 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Lymphoma, T-Cell 2Lymphoma, Large-Cell, Anaplastic 2Dendritic Cell Sarcoma, Interdigitating 2Vomiting 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1Neurotoxicity Syndromes 1Neoplasms, Plasma Cell 1Nausea 1Multiple Myeloma 1Lymphoma, Primary Effusion 1Lymphoma, AIDS-Related 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia, Hairy Cell 1Intraocular Lymphoma 1

Interventions

venetoclax 1prednylidene 1navitoclax 1deltacortene 1Vincristine 1Rituximab 1Prednisone 1Leyk 1Imatinib Mesylate 1Etoposide 1Doxorubicin 1Decitabine 1Cyclophosphamide 1Asparaginase 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Precursor B-Cell Lymphoblastic Leukemia-Lymphoma × Rituximab × Clear all
NCT02538926 2018-11-14

Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin Hydrochloride With Asparaginase in Treating Patients With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

University of Washington

Phase 2 Withdrawn
LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Lymphoma, Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡